Kiora Pharmaceuticals, Inc.
KPRX
$2.84
$0.1917.21%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.11% | -116.30% | -86.17% | 40.77% | 15.00% |
| Total Depreciation and Amortization | 75.98% | 20.99% | 121.89% | -66.51% | -68.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 96.92% | 145.04% | -140.04% | -72.28% | -37.19% |
| Change in Net Operating Assets | -19.96% | -11,832.05% | 446.64% | 782.74% | -301.66% |
| Cash from Operations | -1.87% | -119.85% | 12.74% | 136.50% | -169.58% |
| Capital Expenditure | 37.23% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 103.29% | -- | -- | -- | -- |
| Cash from Investing | 103.13% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.42% | -- | -100.00% | -- | -96.26% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | 100.15% |
| Cash from Financing | 5.95% | -- | 100.00% | -- | -95.78% |
| Foreign Exchange rate Adjustments | 1,780.00% | 119.80% | -161.78% | 306.29% | 124.31% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 88.90% | -100.07% | 37.36% | 63.23% | -645.81% |